Clinical usefulness of measuring tartrate-resistant acid phosphatase 5b in predicting bone turnover in peritoneal dialysis patients

Clinical usefulness of measuring tartrate-resistant acid phosphatase 5b in predicting bone turnover in peritoneal dialysis patients - Clinical Usefulness of measurement of TRACP5b in PD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007524

Enrollment

Registered

2012-03-19

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endstage renal failure patients on peritoneal dialysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who receives peritoneal dialysis treatment at Kyushu University Hospital

Exclusion criteria

Exclusion criteria: Patients who did not give written informed consent

Design outcomes

Primary

Measure	Time frame
To assess the relationship between TRACP5b and other established bone turnover markers	—

Secondary

Measure	Time frame
To determine the effect of residual kidney function and peritoneal dialysis treatment of bone markers includin TRACP5b	—

Countries

Japan

Contacts

Public ContactShunsuke Yamada

Kyushu University Department of Medicine and Clinical Science, Graduate School of Medical Sciences

ana65641@nifty.com092-642-5256

Outcome results